Sort by
Keyphrases
Immunosuppression
100%
Tacrolimus
100%
Calcineurin Inhibitors
100%
Renal Transplantation
100%
Rejection Rate
100%
Early Steroid Withdrawal
100%
High Rejection
100%
Between-group
66%
Acute Rejection
66%
Calcineurin
66%
Mycophenolate Mofetil
66%
Sirolimus
66%
Cardiovascular Disease
33%
High Incidence
33%
Ethical Committee
33%
Single Center
33%
Safety Endpoints
33%
Interim Analysis
33%
Methylprednisolone
33%
Daclizumab
33%
Secondary Safety
33%
Immunosuppressive Protocols
33%
Free Survival
33%
Kaplan-Meier Analysis
33%
Rejection-Free
33%
Medicine and Dentistry
Kidney Transplantation
100%
Tacrolimus
100%
Immunosuppressive Treatment
100%
Calcineurin Inhibitor
100%
Acute Graft Rejection
66%
Calcineurin
66%
Rapamycin
66%
Mycophenolate Mofetil
66%
Cardiovascular Disease
33%
Immunosuppressive Drug
33%
Cardiovascular System
33%
Interim Analysis
33%
Methylprednisolone
33%
Daclizumab
33%
INIS
patients
100%
steroids
100%
kidneys
100%
immunosuppression
100%
cardiovascular diseases
50%
mortality
50%
safety
50%
morbidity
50%
Immunology and Microbiology
Kidney Transplantation
100%
Tacrolimus
100%
Immunosuppression
100%
Acute Graft Rejection
66%
Sirolimus
66%
Mycophenolate Mofetil
66%
Immunosuppressive Drug
33%
Daclizumab
33%
Methylprednisolone
33%
Biochemistry, Genetics and Molecular Biology
Calcineurin
100%
Methylprednisolone
33%
Daclizumab
33%